Verition Fund Management LLC purchased a new stake in Chenghe Acquisition Co. (NASDAQ:CHEAU – Get Rating) during the second quarter, according to its most recent filing with the SEC. The fund purchased 143,366 shares of the company's stock, valued at approximately $1,439,000.
Other large investors have also recently made changes to their positions in the company. Lynwood Capital Management Inc. bought a new stake in shares of Chenghe Acquisition in the 2nd quarter worth about $60,000. Clear Street LLC purchased a new position in shares of Chenghe Acquisition during the 2nd quarter worth about $180,000. Walleye Trading LLC purchased a new position in shares of Chenghe Acquisition during the 2nd quarter worth about $361,000. Linden Advisors LP purchased a new position in shares of Chenghe Acquisition during the 2nd quarter worth about $371,000. Finally, Walleye Capital LLC purchased a new position in shares of Chenghe Acquisition during the 2nd quarter worth about $643,000.
Get Chenghe Acquisition alerts:Chenghe Acquisition Price Performance
CHEAU stock opened at $10.29 on Tuesday. Chenghe Acquisition Co. has a 12 month low of $9.97 and a 12 month high of $10.30. The company has a 50-day moving average price of $10.20 and a 200 day moving average price of $10.11.
Chenghe Acquisition Profile
(Get Rating)Chenghe Acquisition Co focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of financial technology or technology-enabled financial service companies, including artificial intelligence, big data, and cloud and blockchain-related initiatives in Asian markets.
Recommended Stories
- Get a free copy of the StockNews.com research report on Chenghe Acquisition (CHEAU)
- Will Tesla Shares Rally If Musk Steps Down From Twitter?
- 5 Down But Not Out Stocks To Watch For 2023
- Can Chewy Fetch Double Digit Gains in 2023?
- Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
- Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why
Receive News & Ratings for Chenghe Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chenghe Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.